Health Care/Hospital

Immvira Announces the Appointment of Carl Yeung as Chief Financial Officer

SHENZHEN, China, June 30, 2020 /PRNewswire/ -- Today Immvira Group Company (Immvira or the "Company"), a biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, announces the appointment ofCarl Yeung as Chief Financial Officer, report...

2020-07-01 08:30 1823

Lipidor AB (publ) Formalizes Relationship With Subsidiary Emollivet AB Through License Agreement and Proposes Financing of Subsidiary

STOCKHOLM, Sweden, July 1, 2020 /PRNewswire/ -- Lipidor AB ("Lipidor" or the " Company") and its subsidiary Emollivet AB ("Emollivet") have formalized the relationship by entering into a licence agreement that regulates the right to Lipidor's patented AKVANO® technology. OnJune 30, Emollivet's Ext...

2020-07-01 08:06 1580

FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma

DARMSTADT, Germany and NEW YORK, July 1, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BAVENCIO® (avelumab) for the maintenance treatment of patients with...

2020-07-01 07:30 7386

Almost Half of Children Are Not Always Using Soap When Washing Hands at School, New Survey by the Global Hygiene Council Finds

Leading hygiene experts are stressing the importance of effective hand hygiene measures and education in schools as children begin returning to educational settings following the COVID-19 pandemic LONDON, July 1, 2020 /PRNewswire/ -- The calls follow a new global survey conducted by The Global H...

2020-07-01 07:01 2412

Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular Vesicles Platform

CAMBRIDGE, Mass., July 1, 2020 /PRNewswire/ -- Carmine Therapeutics announced today that it has signed a research collaboration agreement with Takeda Pharmaceutical Company Limited ("Takeda") to discover, develop and commercialize transformative non-viral gene therapies for two rare disease targ...

2020-07-01 07:00 2214

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge for Healthcare in the New Normal in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

- QuickFire Challenge calls on innovators to identify and accelerate potential solutions aiming to improve patient care in our post-COVID world. - Awardees will receive up to KRW150,000,000 (approximately US $125,000)[1], residence at the Seoul Bio Hub, and mentorship and coaching from experts at...

2020-07-01 05:30 2343

Golden Meditech Announces FY2019/2020 Annual Results

Revenue Fluctuated during the Pandemic, The Group is Confident to Meet Future Challenges Sustainable Growth in Beijing Sunbow O&G Hospital, Interim Achievements in Cell Therapy Clinical Trials For the Year Ended 31 March 2020 (HK$'000) 2019 (HK$'000) Change (%) Revenue 307,141 315,66...

2020-06-30 22:23 5547

Huntkey Sub-brand OUCICA Won the Outstanding Contribution Award in the Emergency Project of Guangdong Province for the Prevention and Control of New Coronavirus Infection

SHENZHEN, China, June 30, 2020 /PRNewswire/ -- The coronavirus has had a huge impact on the world. In order to fully promote the prevention and control deployment of the epidemic, the Guangdong Provincial Department of Science and Technology leads the "Guangdong Province Special Project on Emerge...

2020-06-30 21:30 1245

AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site

Expansion will help meet the growing demand for plasmid DNA offerings SEATTLE, June 30, 2020 /PRNewswire/ -- Committed to continuous innovation and expansion of its service offerings, AGC Biologics has announced the expansion of its pDNA Center of Excellence in Heidelberg, Germany. The global bi...

2020-06-30 21:00 2008

Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing

SAN DIEGO, June 30, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the launch of AJILITY™, a flexible and agile drug product manufacturing platform, designed to ...

2020-06-30 20:10 1352

One Drop Commended by Frost & Sullivan for Its Industry-leading Connected Glucose Meter and Smartphone Application

SANTA CLARA, California, June 30, 2020 /PRNewswire/ -- Based on its recent analysis of the North American diabetes data management platform market, Frost & Sullivan recognizesOne Drop with the 2020 North America Technology Innovation Leadership Award. One Drop's complete diabetes management platf...

2020-06-30 20:00 1644

Zhejiang Hisun Pharmaceutical: COVID-19 Pandemic Brought Under Control in China With Favipiravir Showing Excellent Clinical Results

TAIZHOU, China, June 30, 2020 /PRNewswire/ -- COVID-19 has become a global pandemic.China's successful control of the pandemic has set a good example for other countries. Many have followedChina to take effective measures like enforcing lockdowns and wearing masks have all been proved to be effec...

2020-06-30 18:51 2247

Shangri-La Partners With Diversey to Upcycle 12,500kg of Hotel Linen Into Half-a-million Reusable Face Masks for the Vulnerable

SINGAPORE, June 30, 2020 /PRNewswire/ -- Vulnerable members in communities across 11 cities inSoutheast Asia and Sri Lanka will soon have greater access to reusable face masks with the regional Linens For Life Face Masks (L4LFM) partnership between Shangri-La Group and Diversey, a leading global ...

2020-06-30 15:51 2423

Release of Initial Attana Virus Analytics-AVA Testing Protocols

STOCKHOLM, June 30, 2020 /PRNewswire/ -- Attana has today released the initial technical protocols for AVA Antibody Testing and will make these available to all existing Attana customers. In close collaboration with Linnaeus University Attana application specialists have been performing studies ...

2020-06-30 15:42 1124

'Curing Cancer without Surgery'

* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer drug, Polytaxel, without side effects such as weight loss." * Suppressed 99.8% of tumors despite a non-toxic dose…more effective than existing FDA-approved pancreatic cancer drugs. * Hopes for a Kore...

2020-06-30 15:10 1294

Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group

ZURICH, June 30, 2020 /PRNewswire/ -- * Workers demand greater flexibility after coronavirus, with a 50/50 split of remote and office time confirmed as the universal ideal * Questions raised over the hours-based contract, with 69% saying contracts should be based on results delivered rather t...

2020-06-30 15:00 2708

Santen and Singapore's Health-tech Start-up, Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia

OSAKA, Japan and SINGAPORE, June 30, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter, Santen) and Plano Pte. Ltd (hereinafter, Plano) today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from S...

2020-06-30 15:00 1682

Thrombosis Research Institute (TRI) Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19

- Clinical trial will recruit approximately 1400 patients in 10 countries starting in July  - Participants will be randomised to receive the low molecular weight Heparin enoxaparin or current standard of care for up to 3 weeks from the time of diagnosis  - The study is supported through an inve...

2020-06-30 14:00 1603

AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis: Initiates Phase 2b Clinical Trial in Adults

AOBiome's 576 patient Phase 2b trial commences patient enrollment CAMBRIDGE, Massachusetts, June 30, 2020 /PRNewswire/ -- AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammation,  announced initiation of a Phase2b clinical trial in pruritus (i...

2020-06-30 13:00 1069

Art Travel Shoe Brand UIN Footwear Gives Away Shoes to Frontline Nurses Worldwide

BARCELONA, Spain, June 30, 2020 /PRNewswire/ -- Nurses and healthcare workers are the heroes of our time. Every day for months they have been risking their lives to stand by our bedsides, helping and caring for us during this global coronavirus pandemic. Now UIN Footwear is recognizing their effo...

2020-06-30 12:10 1388
1 ... 659660661662663664665 ... 808